This may involve an ophthalmologist, a specialist in eye diseases. The first line of treatment is the tight control of your blood sugar levels. In early diabetes, dietary changes (limiting sugary ...

An A1C below 5.7% is normal, 5.7% to 6.4% signals prediabetes, and 6.5% or higher on two tests confirms diabetes. With the right treatment and lifestyle changes, you can lower your A1C and reduce ...

Over time, if a person does not receive treatment, venous insufficiency can ... as it helps increase blood flow to the lower legs. Other forms of low impact exercise, such as biking, swimming ...

one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is leading a ...

Glaucoma occurs when pressure builds up in the eye and restricts blood flow ... ve had diabetes, the higher the chance for complications, especially if you haven’t followed a treatment plan.

we’re thinking about how the discoveries we make in the lab will make life better for the people who have to manage diabetes every day,” Doloff said. The immunoengineering technologies being created ...

we're thinking about how the discoveries we make in the lab will make life better for the people who have to manage diabetes every day," Doloff said. The immunoengineering technologies being created ...

It rarely requires treatment, and habit changes can often ... The erectile tubes produce erections when engorged with blood, so less blood flow means smaller or fewer firm erections.

Several domestic drug companies today launched the blockbuster diabetes drug Empagliflozin with domestic drugmaker- Mankind pharma launching it at 90 per cent less than the innovator price. The move ...

When your blood sugar levels fall within the recommended ranges, it’s a sign your diabetes treatment and management plan is working. You and your doctor can determine your exact blood sugar targets.

The findings of the study were published Diabetes Technology & Therapeutics ... that targeted therapies could complement insulin treatment, providing additional benefits in glycemic control ...

According to a Lancet study, 101 million people in India – 11.4 percent of the country’s population – are living with diabetes. While Metformin remains the standard first-line treatment for ...